Style | Citing Format |
---|---|
MLA | Aghdam KA, et al.. "Pituitary Apoplexy Secondary to Thrombocytopenia Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Report of a Rare Case and Literature Review." Journal of Current Ophthalmology, vol. 34, no. 3, 2022, pp. 364-368. |
APA | Aghdam KA, Abtahi ZA, Sonbolestan SA, Sanjari MS (2022). Pituitary Apoplexy Secondary to Thrombocytopenia Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Report of a Rare Case and Literature Review. Journal of Current Ophthalmology, 34(3), 364-368. |
Chicago | Aghdam KA, Abtahi ZA, Sonbolestan SA, Sanjari MS. "Pituitary Apoplexy Secondary to Thrombocytopenia Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Report of a Rare Case and Literature Review." Journal of Current Ophthalmology 34, no. 3 (2022): 364-368. |
Harvard | Aghdam KA et al. (2022) 'Pituitary Apoplexy Secondary to Thrombocytopenia Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Report of a Rare Case and Literature Review', Journal of Current Ophthalmology, 34(3), pp. 364-368. |
Vancouver | Aghdam KA, Abtahi ZA, Sonbolestan SA, Sanjari MS. Pituitary Apoplexy Secondary to Thrombocytopenia Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Report of a Rare Case and Literature Review. Journal of Current Ophthalmology. 2022;34(3):364-368. |
BibTex | @article{ author = {Aghdam KA and Abtahi ZA and Sonbolestan SA and Sanjari MS}, title = {Pituitary Apoplexy Secondary to Thrombocytopenia Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Report of a Rare Case and Literature Review}, journal = {Journal of Current Ophthalmology}, volume = {34}, number = {3}, pages = {364-368}, year = {2022} } |
RIS | TY - JOUR AU - Aghdam KA AU - Abtahi ZA AU - Sonbolestan SA AU - Sanjari MS TI - Pituitary Apoplexy Secondary to Thrombocytopenia Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Report of a Rare Case and Literature Review JO - Journal of Current Ophthalmology VL - 34 IS - 3 SP - 364 EP - 368 PY - 2022 ER - |